CNBC Daily Open: Better-than-expected U.S. jobs report and AI fears spook markets
U.S. stocks went down after the report came out Wednesday stateside, with the Dow snapping a three-day winning streak.
Japan stocks extend post-election rally with Nikkei 225 breaching 58,000 for the first time
Other markets in Asia also shrugged off strong U.S. payrolls data that has dampened expectations for Federal Reserve rate cuts and sent Wall Street lower overnight.
Dow slides 600 points, S&P 500 falls for a third day as AI disruption fears rattle markets: Live updates
Wall Street is coming off a weak session for the major averages as traders assessed what the latest jobs report means for the interest rate outlook.
Epstein files: AG Pam Bondi seemed to have Rep. Jayapal’s DOJ database search history at hearing
Attorney General Pam Bondi at a House Judiciary Committee hearing seemed to have a printout of Rep. Jayapal’s search history related to Epstein.
Trump orders Pentagon to buy power from coal plants
Trump declared coal essential to U.S. national and economic security last April.
Cisco’s stock drops 7% on mediocre forecast even as earnings and revenue top estimates
Cisco reported revenue growth in the quarter of close to 10%, topping analysts’ estimates.
Novo Nordisk faces a defining year in the obesity drug market. It’s off to a dramatic start
The Danish drugmaker kicked off 2026 with its explosive obesity pill launch, but recent challenges have centered around protecting its market share.
These funds protect against market drops. Demand is booming
Buffer ETFs could see assets quadruple over a five-year period, according to Cerulli Associates. What to know before investing.
Tariff revenue soars more than 300% as U.S. awaits Supreme Court decision
The U.S. government in January ran up a smaller deficit than a year ago, while tariff collections surged.
Novo Nordisk CEO sees 15 million patient opportunity in Medicare coverage for obesity drugs
Doustdar said Medicare coverage and the launch of Novo’s new obesity pill should help gradually boost prescription volumes and offset lower prices in the U.S.
